Donald D. Muccio
Affiliations: | University of Alabama, Birmingham, Birmingham, AL, United States |
Area:
Biochemistry, Microbiology BiologyGoogle:
"Donald Muccio"Children
Sign in to add trainee| Yi-Chien Lee | grad student | 2001 | UAB |
| Kimberly K. Vines | grad student | 2001 | UAB |
| Brandon S. Pybus | grad student | 2002 | UAB |
| Gang Xia | grad student | 2010 | UAB |
| Bryan D. Cox | grad student | 2012 | UAB |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Williams AP, Waters AM, Stewart JE, et al. (2018) A novel retinoid X receptor agonist, UAB30, inhibits rhabdomyosarcoma cells in vitro. The Journal of Surgical Research. 228: 54-62 |
| Chou CF, Hsieh YH, Grubbs CJ, et al. (2018) The retinoid X receptor agonist, 9-cis UAB30, inhibits cutaneous T-cell lymphoma proliferation through the SKP2-p27kip1 axis. Journal of Dermatological Science |
| Muccio DD, Atigadda VR, Brouillette WJ, et al. (2016) Translation of a Tissue-Selective Rexinoid, UAB30, to the Clinic for Breast Cancer Prevention. Current Topics in Medicinal Chemistry |
| Wu L, Chaudhary SC, Atigadda VR, et al. (2016) Retinoid X Receptor Agonists Upregulate Genes Responsible for the Biosynthesis of All-Trans-Retinoic Acid in Human Epidermis. Plos One. 11: e0153556 |
| Atigadda VR, Xia G, Deshpande A, et al. (2015) Conformationally Defined Rexinoids and Their Efficacy in the Prevention of Mammary Cancers. Journal of Medicinal Chemistry. 58: 7763-74 |
| Waters AM, Stewart JE, Atigadda VR, et al. (2015) Preclinical Evaluation of a Novel RXR Agonist for the Treatment of Neuroblastoma. Molecular Cancer Therapeutics |
| Atigadda VR, Xia G, Desphande A, et al. (2014) Methyl substitution of a rexinoid agonist improves potency and reveals site of lipid toxicity. Journal of Medicinal Chemistry. 57: 5370-80 |
| Desphande A, Xia G, Boerma LJ, et al. (2014) Methyl-substituted conformationally constrained rexinoid agonists for the retinoid X receptors demonstrate improved efficacy for cancer therapy and prevention. Bioorganic & Medicinal Chemistry. 22: 178-85 |
| Boerma LJ, Xia G, Qui C, et al. (2014) Defining the communication between agonist and coactivator binding in the retinoid X receptor α ligand binding domain. The Journal of Biological Chemistry. 289: 814-26 |
| Cox BD, Muccio DD, Hamilton TP. (2013) Conformational Analysis of Retinoic Acids: Effects of Steric Interactions on Nonplanar Conjugated Polyenes. Computational & Theoretical Chemistry. 1011: 11-20 |